학술논문
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
Document Type
Article
Author
Moretto, Roberto; Rossini, Daniele; Capone, Iolanda; Boccaccino, Alessandra; Perrone, Federica; Tamborini, Elena; Masi, Gianluca; Antoniotti, Carlotta; Marmorino, Federica; Conca, Veronica; Borelli, Beatrice; Martignetti, Angelo; Pecora, Irene; Simionato, Francesca; Cupini, Samanta; Ambrosini, Margherita; Manca, Paolo; Pietrantonio, Filippo; Falcone, Alfredo; Cremolini, Chiara
Source
In Clinical Colorectal Cancer December 2021 20(4):314-317
Subject
Language
ISSN
1533-0028